These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 31520103)

  • 1. Less is more: catecholamine-sparing strategies in septic shock.
    Venkatesh B; Khanna AK; Cohen J
    Intensive Care Med; 2019 Dec; 45(12):1810-1812. PubMed ID: 31520103
    [No Abstract]   [Full Text] [Related]  

  • 2. Vasopressor dosing in septic shock.
    Alaniz C; Pollard S
    Crit Care Med; 2013 Dec; 41(12):e483-4. PubMed ID: 24275412
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of exogenous arginine vasopressin in the management of catecholamine-refractory septic shock.
    Lee CS
    Crit Care Nurse; 2006 Dec; 26(6):17-23. PubMed ID: 17123948
    [No Abstract]   [Full Text] [Related]  

  • 4. The authors reply.
    Annane D; Dellinger RP
    Crit Care Med; 2013 Dec; 41(12):e484. PubMed ID: 24275413
    [No Abstract]   [Full Text] [Related]  

  • 5. Dear vasopressin, where is your place in septic shock?
    Duenser MW; Hasibeder WR
    Crit Care; 2005 Apr; 9(2):134-5. PubMed ID: 15774061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimodal strategy to counteract vasodilation in septic shock.
    Leone M; Einav S; Antonucci E; Depret F; Lakbar I; Martin-Loeches I; Wieruszewski PM; Myatra SN; Khanna AK
    Anaesth Crit Care Pain Med; 2023 Jun; 42(3):101193. PubMed ID: 36621622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: a retrospective analysis.
    Dünser MW; Mayr AJ; Ulmer H; Ritsch N; Knotzer H; Pajk W; Luckner G; Mutz NJ; Hasibeder WR
    Anesth Analg; 2001 Jul; 93(1):7-13. PubMed ID: 11429329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vasopressin in distributive shock : Brief summary of the guidelines of the Canadian Critical Care Society published in December 2019].
    Bayerl S; Wöhrle T; Kilger E
    Anaesthesist; 2020 Mar; 69(3):159-161. PubMed ID: 32055884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New evidence for old therapies in catecholamine-dependent septic shock.
    Friedrich JO; Lapinsky SE
    Intensive Care Med; 2001 Apr; 27(4):787-90. PubMed ID: 11398711
    [No Abstract]   [Full Text] [Related]  

  • 10. Broad spectrum vasopressors: a new approach to the initial management of septic shock?
    Chawla LS; Ostermann M; Forni L; Tidmarsh GF
    Crit Care; 2019 Apr; 23(1):124. PubMed ID: 30992045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A normal response to Synachten test does not rule out corticosteroid effectiveness in weaning from catecholamine after septic shock.
    Cavaliere F; Craba A; Caputo C; Gaspari R; Conti G; Proietti R
    Minerva Anestesiol; 2007 Jun; 73(6):367-70. PubMed ID: 17589424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between norepinephrine dose, tachycardia and outcome in septic shock: A multicentre evaluation.
    Domizi R; Calcinaro S; Harris S; Beilstein C; Boerma C; Chiche JD; D'Egidio A; Damiani E; Donati A; Koetsier PM; Madden MP; McAuley DF; Morelli A; Pelaia P; Royer P; Shankar-Hari M; Wickboldt N; Zolfaghari P; Singer M
    J Crit Care; 2020 Jun; 57():185-190. PubMed ID: 32171905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vasodilatory septic shock refractory to catecholamines: is there a role for terlipressin?].
    Fellahi JL; Bénard P; Daccache G; Mourgeon E; Gérard JL
    Ann Fr Anesth Reanim; 2003 Jul; 22(7):631-4. PubMed ID: 12946495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrocortisone Therapy in Catecholamine-Resistant Pediatric Septic Shock: A Pragmatic Analysis of Clinician Practice and Association With Outcomes.
    Nichols B; Kubis S; Hewlett J; Yehya N; Srinivasan V
    Pediatr Crit Care Med; 2017 Sep; 18(9):e406-e414. PubMed ID: 28658197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Norepinephrine in fluid-refractory catecholamine-resistant cold shock: are we sure?
    Silvani P
    Crit Care Med; 2009 Jul; 37(7):2322-3; author reply 2323. PubMed ID: 19535935
    [No Abstract]   [Full Text] [Related]  

  • 16. Terlipressin in the treatment of late phase catecholamine-resistant septic shock.
    Svoboda P; Scheer P; Kantorová I; Doubek J; Dudra J; Radvan M; Radvanova J
    Hepatogastroenterology; 2012 Jun; 59(116):1043-7. PubMed ID: 22580654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recently published papers: Sepsis--guidelines, treatment and novel approaches.
    Kalsi N; Forni LG
    Crit Care; 2008; 12(2):120. PubMed ID: 18394177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does the Addition of Vasopressin to Catecholamine Vasopressors Affect Outcomes in Patients With Distributive Shock?
    Roumpf SK; Hunter BR
    Ann Emerg Med; 2019 Jul; 74(1):153-155. PubMed ID: 30446352
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of terlipressin in the treatment of infants and neonates with catecholamine-resistant septic shock.
    Leone M; Martin C
    Best Pract Res Clin Anaesthesiol; 2008 Jun; 22(2):323-33. PubMed ID: 18683478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the addition of vasopressin to norepinephrine beneficial for the treatment of septic shock?
    Sandifer JP; Jones AE
    Ann Emerg Med; 2013 Nov; 62(5):534-535. PubMed ID: 23683544
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.